Gene set enrichment analysis identified enrichment of spliceosome factors in EOCRC samples, and we further identified differential AS events encoding tumor-specific neoantigens, some of which were predicted to strongly bind the major histocompatibility complex (MHC). The gene discussed is HLA-C; the disease is neoplasm.